Alpha-synuclein co-pathology in a real-world early Alzheimer's disease cohort.

Saved in:
Bibliographic Details
Title: Alpha-synuclein co-pathology in a real-world early Alzheimer's disease cohort.
Authors: Shiner T; Cognitive Neurology Unit, Neurological Institute, Tel Aviv Medical Center, Tel Aviv, Israel.; Gray Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.; Movement Disorders Unit, Neurological Institute, Tel Aviv Medical Center, Tel Aviv, Israel., Nathan T; Cognitive Neurology Unit, Neurological Institute, Tel Aviv Medical Center, Tel Aviv, Israel., Levy MH; Cognitive Neurology Unit, Neurological Institute, Tel Aviv Medical Center, Tel Aviv, Israel., David AB; Cognitive Neurology Unit, Neurological Institute, Tel Aviv Medical Center, Tel Aviv, Israel., Omer N; Cognitive Neurology Unit, Neurological Institute, Tel Aviv Medical Center, Tel Aviv, Israel.; Movement Disorders Unit, Neurological Institute, Tel Aviv Medical Center, Tel Aviv, Israel., Awad AA; Cognitive Neurology Unit, Neurological Institute, Tel Aviv Medical Center, Tel Aviv, Israel., Ash E; Cognitive Neurology Unit, Neurological Institute, Tel Aviv Medical Center, Tel Aviv, Israel.; Gray Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel., Weisz MG; Laboratory of Biomarkers and Genomics of Neurodegeneration, Tel Aviv, Israel., Goldstein O; Laboratory of Biomarkers and Genomics of Neurodegeneration, Tel Aviv, Israel., Alcalay Y; Division of Clinical Laboratories, Tel Aviv Medical Center, Tel Aviv, Israel., Regev K; Gray Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.; Neuroimmunology Unit, Tel Aviv Medical Center, Tel Aviv, Israel., Lamoureux J; Amprion, Inc., San Diego, California, USA., Van Keuren-Jensen K; Center for Alzheimer's and Related Dementias, National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.; Bioinnovation and Genome Sciences, The Translational Genomics Research Institute, Phoenix, Arizona, USA., Blauwendraat C; Center for Alzheimer's and Related Dementias, National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA., Alcalay RN; Gray Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.; Movement Disorders Unit, Neurological Institute, Tel Aviv Medical Center, Tel Aviv, Israel.; Laboratory of Biomarkers and Genomics of Neurodegeneration, Tel Aviv, Israel., Bregman N; Cognitive Neurology Unit, Neurological Institute, Tel Aviv Medical Center, Tel Aviv, Israel.; Gray Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.
Source: Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2026 Mar; Vol. 22 (3), pp. e71240.
Publication Type: Journal Article
Journal Info: Publisher: John Wiley & Sons, Ltd Country of Publication: United States NLM ID: 101231978 Publication Model: Print Cited Medium: Internet ISSN: 1552-5279 (Electronic) Linking ISSN: 15525260 NLM ISO Abbreviation: Alzheimers Dement Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1552-5279
DOI:10.1002/alz.71240